Status:
ACTIVE_NOT_RECRUITING
Peripheral Nerve Injections for CRPS
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Complex Regional Pain Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Background Complex regional pain syndrome (CRPS) is characterized by intense pain, loss of function, and associated with motor, trophic, sudomotor, and/or vasomotor changes of the affected extremity. ...
Eligibility Criteria
Inclusion
- Able to provide signed and dated informed consent form
- Male or female, aged ≥18 years old
- Satisfy the Budapest Criteria for upper extremity CRPS
- A VAS score of at least 40 mm in the upper extremity to avoid flooring effect for injection-related pain reduction
Exclusion
- Uncontrolled hypertension (\>180/110)
- Sepsis
- Bleeding diathesis
- Active cancer
- Brachial plexus injuries
- Neurological language deficits precluding participation
- Mini mental state examination score \< 23
- Acute mental illness (An acute mental illness is characterized by clinically significant symptoms of any metal health illness that requires immediate treatment. The physician making the recommendation to be part of the study. If the patient exhibits symptoms of any mental health illness that is not being treated by either the recommending physician or another member of the patient's care team the patient will not be recommended to participate in the study)
- Patients who are pregnant or breastfeeding
Key Trial Info
Start Date :
May 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04744675
Start Date
May 30 2024
End Date
June 1 2025
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
2
Elisabeth Bruyere Hospital
Ottawa, Ontario, Canada, K1N5C8